138 related articles for article (PubMed ID: 30979536)
1. Inhibitory kinetics of fruit components on CYP2C19 activity.
Seki H; Akiyoshi T; Imaoka A; Ohtani H
Drug Metab Pharmacokinet; 2019 Jun; 34(3):181-186. PubMed ID: 30979536
[TBL] [Abstract][Full Text] [Related]
2. Analysis of inhibition kinetics of three beverage ingredients, bergamottin, dihydroxybergamottin and resveratrol, on CYP2C9 activity.
Akiyoshi T; Uchiyama M; Inada R; Imaoka A; Ohtani H
Drug Metab Pharmacokinet; 2022 Feb; 42():100429. PubMed ID: 34979453
[TBL] [Abstract][Full Text] [Related]
3. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
4. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
Paine MF; Criss AB; Watkins PB
J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
[TBL] [Abstract][Full Text] [Related]
5. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus.
Masuda M; Watanabe S; Tanaka M; Tanaka A; Araki H
J Clin Pharm Ther; 2018 Feb; 43(1):15-20. PubMed ID: 28749005
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
7. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
Kakar SM; Paine MF; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
[TBL] [Abstract][Full Text] [Related]
8. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
9. New grapefruit cultivars exhibit low cytochrome P4503A4-Inhibition activity.
Guttman Y; Yedidia I; Nudel A; Zhmykhova Y; Kerem Z; Carmi N
Food Chem Toxicol; 2020 Mar; 137():111135. PubMed ID: 31968226
[TBL] [Abstract][Full Text] [Related]
10. The Molecular and Enzyme Kinetic Basis for Altered Activity of Three Cytochrome P450 2C19 Variants Found in the Chinese Population.
Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
Curr Mol Pharmacol; 2020; 13(3):233-244. PubMed ID: 31713493
[TBL] [Abstract][Full Text] [Related]
11. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity.
Messer A; Raquet N; Lohr C; Schrenk D
Food Chem Toxicol; 2012 Mar; 50(3-4):756-60. PubMed ID: 22155270
[TBL] [Abstract][Full Text] [Related]
12. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
[TBL] [Abstract][Full Text] [Related]
13. Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
Yamasaki K; Iohara D; Oyama Y; Nishizaki N; Kawazu S; Nishi K; Kadowaki D; Taguchi K; Otagiri M; Seo H
J Pharm Pharmacol; 2020 Mar; 72(3):356-363. PubMed ID: 31828807
[TBL] [Abstract][Full Text] [Related]
14. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
15. [Contents of furanocoumarins in grapefruit juice and health foods].
Sakamaki N; Nakazato M; Matsumoto H; Hagino K; Hirata K; Ushiyama H
Shokuhin Eiseigaku Zasshi; 2008 Aug; 49(4):326-31. PubMed ID: 18787320
[TBL] [Abstract][Full Text] [Related]
16. Effect of maturity, processing, and storage on the furanocoumarin composition of grapefruit and grapefruit juice.
Cancalon PF; Barros SM; Haun C; Widmer WW
J Food Sci; 2011 May; 76(4):C543-8. PubMed ID: 22417333
[TBL] [Abstract][Full Text] [Related]
17. The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway.
Ford NF
J Clin Pharmacol; 2016 Dec; 56(12):1474-1483. PubMed ID: 27196064
[TBL] [Abstract][Full Text] [Related]
18. [Furanocoumarins contents and cytochrome P450 3A (CYP3A) inhibitory activities of various processed fruit peel products: outflow of 6',7'-Dihydroxybergamottin during processing treatment of peel].
Ishihara M; Toda H; Sunagane N; Ohta T
Yakugaku Zasshi; 2011; 131(5):679-84. PubMed ID: 21532264
[TBL] [Abstract][Full Text] [Related]
19. The use of heat treatment to eliminate drug interactions due to grapefruit juice.
Uesawa Y; Mohri K
Biol Pharm Bull; 2006 Nov; 29(11):2274-8. PubMed ID: 17077528
[TBL] [Abstract][Full Text] [Related]
20. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties.
Paine MF; Criss AB; Watkins PB
Drug Metab Dispos; 2004 Oct; 32(10):1146-53. PubMed ID: 15269184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]